RedHill Biopharma (RDHL) Intangibles (2011 - 2026)
RedHill Biopharma's Intangibles came in at $5.29 million for the quarter ended Jun 30, 2026, down 4.3% from $5.53 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Intangibles (2011 - 2026) Analysis & Trends
Going back to the quarter ended Dec 31, 2011, RedHill Biopharma's Intangibles data covers 50 quarters.
- Intangibles has declined in each of the last five years, with a five-year compound annual growth rate of -43.0% (years ended Dec 2020 to Dec 2025).
- Going back by year, Intangibles was $5.55 million in the year ended Dec 31, 2024 (-0.6%), $5.58 million in the year ended Dec 31, 2023 (-91.5%), $65.63 million in the year ended Dec 31, 2022 (-8.4%) and $71.64 million in the year ended Dec 31, 2021 (-18.5%).
- The five-year range for quarterly Intangibles is $5.29 million (the quarter ended Dec 31, 2025) to $82.39 million (the quarter ended Sep 30, 2021).
- The year-over-year decline in Intangibles has ranged between 0.6% (the quarter ended Jun 30, 2024) and 92.0% (the quarter ended Mar 31, 2023) over the last five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.76 Bn | 1,105.35 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 618.64 Bn | 537.17 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 502.02 Bn | 475.13 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 368.10 Bn | 322.48 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 297.96 Bn | 261.95 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 261.11 Bn | 234.80 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 236.64 Bn | 192.04 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 191.15 Bn | 165.35 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 169.69 Bn | 116.33 Bn | 10.94 Bn | 47.05 Bn |
| 10 | RedHill Biopharma | 1.45 Mn | -15.16 Mn | - | 5.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.29 Mn |
| Dec 31, 2025 | 5.29 Mn |
| Jun 30, 2025 | 5.53 Mn |
| Dec 31, 2024 | 5.55 Mn |
| Jun 30, 2024 | 5.56 Mn |
| Dec 31, 2023 | 5.58 Mn |
| Jun 30, 2023 | 5.59 Mn |
| Mar 31, 2023 | 5.60 Mn |
| Dec 31, 2022 | 65.63 Mn |
| Sep 30, 2022 | 67.14 Mn |
| Jun 30, 2022 | 68.74 Mn |
| Mar 31, 2022 | 70.04 Mn |
| Dec 31, 2021 | 71.64 Mn |
| Sep 30, 2021 | 82.39 Mn |
| Jun 30, 2021 | 84.22 Mn |
| Mar 31, 2021 | 86.05 Mn |
| Dec 31, 2020 | 87.88 Mn |
| Sep 30, 2020 | 89.96 Mn |
| Jun 30, 2020 | 79.52 Mn |
| Mar 31, 2020 | 15.85 Mn |
API Access
RedHill Biopharma Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();